Skip to main content
OpenTrials
Completed

NCT Number: NCT03605875

A Web Application for Improving Communication on Hemodialysis Rounds

To evaluate a web application tool that hemodialysis patients can use outside of dialysis time to log and prioritize their concerns for the nephrologists. Specifically, the investigators will compare the usability of a web application tool to a structured paper form. The investigators will also use data from semi-structured interviews to better understand the experience and acceptability of the web app among patient participants randomized to the web application and among participating nephrologists.

Primary outcome

-Usability (effectiveness, efficiency, satisfaction)

Secondary outcomes

-Quality of the patient-physician interaction (Communication Assessment Tool (CAT-14))

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemodialysis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Edmonton General Hospital, Edmonton, Alberta, Canada

Loading trial locations.

About this study

Usability is defined as Effectiveness (>70%)

  • Number of people submitting a concern/ number of people with opportunity to submit a concern
  • Number of concerns entered/number of times concern was satisfactorily addressed

Efficiency

  • Proportion of non-completed tasks (<70%)
  • The amount of time to complete one concern

Satisfaction

  • Semistructured interviews
  • Usability survey

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Chronic in-center hemodialysis patients in Edmonton, Alberta and Winnipeg, Manitoba
  • Able to provide consent, understand and read English or have a family member that can do this for them

Exclusion criteria

  • Planning to change modality within the next year

Treatment and study plan

Web-App

Behavioral

Cambian IT Health solutions from Surrey BC developed the infrastructure

Paper

Behavioral

Contains similar questions to the Web-App tool

Primary outcomes

  1. Effectiveness - Number of patients submitting a concern divided by the number of patients

    Time frame: 8 weeks

    Number of patients submitting a concern divided by the number of patients with an opportunity to submit a concern

  2. Effectiveness - Number of concerns entered divided by the number of concerns that were satisfactorily addressed

    Time frame: 8 weeks

    Number of concerns entered divided by the number of concerns that were satisfactorily addressed

  3. Efficiency - The amount of time to complete one concern

    Time frame: 8 weeks

    The amount of time to log a concern in the web app

  4. Satisfaction - Usability survey

    Time frame: 8 weeks

    Usability survey Defined as greater than 70% of users who agree or strongly agree with the statement on the usability survey. Ranked on a 5 -point Likert scale

Secondary outcomes

  1. Communication Assessment Tool

    Time frame: 8 weeks

    Items rated from 1 (poor) to 5 (excellent). Published at Makoul et al. Patient Educ Couns 2007

Sponsors and collaborators

Lead sponsor

University of Alberta

Other

Registry information

Official study title

Voicing Individual Concerns for Engagement in Hemodialysis (VOICE-HD): a Web Application for Rounds

Important dates

Study start
2018
Primary completion
2018
Study completion
2019
First posted
Jul 30, 2018
Registry last updated
Mar 25, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.